89 related articles for article (PubMed ID: 3753129)
1. Cushing's syndrome from the therapeutic use of intramuscular dexamethasone acetate.
Hughes JM; Hichens M; Booze GW; Thorner MO
Arch Intern Med; 1986 Sep; 146(9):1848-9. PubMed ID: 3753129
[TBL] [Abstract][Full Text] [Related]
2. [Cushing's syndrome secondary to nasal instillation of dexamethasone].
Estruch R; Tassies D; Beltrán J; Halperin EI
Rev Clin Esp; 1991 Nov; 189(7):344-5. PubMed ID: 1767094
[No Abstract] [Full Text] [Related]
3. Outbreak of exogenous Cushing's syndrome due to unlicensed medications.
Azizi F; Jahed A; Hedayati M; Lankarani M; Bejestani HS; Esfahanian F; Beyraghi N; Noroozi A; Kobarfard F
Clin Endocrinol (Oxf); 2008 Dec; 69(6):921-5. PubMed ID: 18462262
[TBL] [Abstract][Full Text] [Related]
4. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
[TBL] [Abstract][Full Text] [Related]
5. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
[TBL] [Abstract][Full Text] [Related]
6. [Cushing's syndrome induced by the use of dexamethasone administered nasally in spray form. Report of 3 cases].
Halpern A; Hayahida CY; Pereira MA; Doi Sde Q; Lottenberg SA; Legrazie MC; Schnaider J; Carneiro CR; Bettarello A
Rev Hosp Clin Fac Med Sao Paulo; 1981 Feb; 36(1):18-20. PubMed ID: 7280461
[No Abstract] [Full Text] [Related]
7. Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese.
Ness-Abramof R; Nabriski D; Apovian CM; Niven M; Weiss E; Shapiro MS; Shenkman L
Obes Res; 2002 Dec; 10(12):1217-21. PubMed ID: 12490665
[TBL] [Abstract][Full Text] [Related]
8. Nocturnal 8 mg dexamethasone suppression test: a practical and accurate test for identification of the cause of endogenous Cushing's syndrome.
Sriussadaporn S; Ploybutr S; Peerapatdit T; Plengvidhya N; Nitiyanant W; Vannasaeng S; Vichayanrat A
Br J Clin Pract; 1996; 50(1):9-13. PubMed ID: 8729595
[TBL] [Abstract][Full Text] [Related]
9. [Cushing's syndrome secondary to nasal instillation of dexamethasone].
Domínguez Ortega L
Rev Clin Esp; 1992 Jul; 191(3):169. PubMed ID: 1502409
[No Abstract] [Full Text] [Related]
10. [The diagnosis of Cushing's disease by the nocturnal dexamethasone administration test].
Vázquez Chávez C; Miranda Ruíz R; Acevedo Rivera K; Velasco y Aranzolo GR; Brito Zurita OR; López Félix B
Gac Med Mex; 1993; 129(4):263-6. PubMed ID: 7926413
[TBL] [Abstract][Full Text] [Related]
11. Cushing's syndrome from Klack's solution.
Lankford HV
Endocr Pract; 2000; 6(6):456-8. PubMed ID: 11155219
[TBL] [Abstract][Full Text] [Related]
12. [Cushing's syndrome and adrenal gland depression caused by intranasal spray containing dexamethasone in 2 siblings].
Varotti C; Passarini B; Pasquali R
G Ital Dermatol Venereol; 1987 Mar; 122(3):121-3. PubMed ID: 3596646
[No Abstract] [Full Text] [Related]
13. An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: limitations in patients with mild and/or episodic hypercortisolism.
Friedman TC
Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):356-60. PubMed ID: 16915537
[TBL] [Abstract][Full Text] [Related]
14. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
Castro M; Elias LL; Elias PC; Moreira AC
Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
[TBL] [Abstract][Full Text] [Related]
15. [Iatrogenic Cushing's syndrome caused by dexamethasome suppositories].
Vilaseca J; Tor J; Libenson C; Guardia J
Rev Clin Esp; 1980 Dec; 159(6):437-8. PubMed ID: 7221114
[No Abstract] [Full Text] [Related]
16. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
17. [Prolonged fever of obscure etiology associated with Cushing's syndrome caused by self medication with dexamethasone].
de Arruda Júnior ER
AMB Rev Assoc Med Bras; 1986; 32(1-2):38. PubMed ID: 3491390
[No Abstract] [Full Text] [Related]
18. Florid Cushing's syndrome and hirsutism induced by desoximetasone.
Himathongkam T; Dasanabhairochana P; Pitchayayothin N; Sriphrapradang A
JAMA; 1978 Jan; 239(5):430-1. PubMed ID: 621843
[No Abstract] [Full Text] [Related]
19. Cushing's syndrome complicating pregnancy. A case report.
Wieland RG; Shaffer MB; Glove RP
Obstet Gynecol; 1971 Dec; 38(6):841-3. PubMed ID: 5125430
[TBL] [Abstract][Full Text] [Related]
20. [Cushing syndrome following external glucocorticoid administration in psoriasis].
Dhein S
Z Hautkr; 1986 Feb; 61(3):161-6. PubMed ID: 3953135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
